Zobrazeno 1 - 10
of 36
pro vyhledávání: ''
Autor:
Abul Kalam Najmi, Quamrul Hassan, Mohd Akhtar, Sayeed Akhtar, Zeeba S Jairajpuri, Ramsha Iqbal
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 41(5)
Pitavastatin inhibits 3 hydroxy 3 methyl glutaryl coenzyme A (HMGCoA) reductase enzyme, preventing cholesterol synthesis along with elevating high density apolipoprotein A1 (Apo-A1). The present study was designed to evaluate cardioprotective potenti
Autor:
Qunying Xi, Wei-Hua Liu, Hong-Liang Zhang, Zhihong Liu, Zhihui Zhao, Yong Wang, Qin Luo, Xiao-Hong Xu
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 40(3)
BACKGROUND Recent research has shown that statins improve pulmonary arterial hypertension (PAH), but their mechanisms of action are not fully understood. This study aimed to investigate the role of RhoA/ROCK1 regulation in the therapeutic effects of
Autor:
Oscar A López, María C. Castillo, Jorge López, Gustavo Guevara, Jair Lozano, Enrique F. Castillo, Ruth M. López, José A Morales, Janette E López
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 39(3)
In endothelium-denuded abdominal (but not thoracic) aortas of rats, the nonselective cyclooxygenase (COX) inhibitor, indomethacin, suppressed contractions evoked by α-adrenergic agonists hypothetically mediated by prostanoids. We aimed to identify t
Autor:
Xiushan Dong, Yan Wang
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 38(2)
Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, induces endothelial dysfunction. Nebivolol, a highly selective β1-adrenergic receptor (AR) blocker, is the only beta-blocker known to induce vascular production
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 35(8)
While it is known that non-steroidal anti-inflammatory drugs including selective cyclooxygenase-2 (COX-2) inhibitors influence BP, the exact relationship and underlying mechanisms are still unclear. We investigated the effect of etoricoxib, a selecti
Autor:
Tatiana Sousa Cunha, Marie Doki Nogueira, Fernanda Aparecida Ronchi, Juliana Almada Colucci, Lilian Saemi Arita, Dulce Elena Casarini, Danielle Sanches Aragão, Juliana Dinéia Perez, Vicente de Paulo Castro Teixeira, Danielle Yuri Arita
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 34(6)
Local activation of the renin–angiotensin system (RAS) has been implicated in the pathogenesis of several renal disorders. In this study we investigated how chronic kidney disease (CKD) modulates RAS components in an experimental model. Male Wistar
Autor:
Makoto Nagasaka, Hajime Kurosawa, Masayuki Kanazawa, Masahiro Kohzuki, Naoyoshi Minami, Nobuyoshi Mori, Qi Guo, Osamu Ito
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 32(2)
Physical fitness is closely related to cardiovascular health. We examined the effects of estradiol, angiotensin-converting enzyme inhibitor, exercise training, and their combination on exercise capacity as well as skeletal muscle fiber type and capil
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 30(7)
The interaction of salt sensitivity and obesity in development of cardiac hypertrophy is incompletely understood. The SHHF/Mcc-fa(cp) (SHHF) rat model was used to examine the effect of high salt on cardiac hypertrophy and expression of endothelin (ET
Autor:
Alberto Carlos Botazzo Delbem, Gracieli Prado Elias, Cristina Antoniali, Kikue Takebayashi Sassaki
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 30(2)
The salivary activity in pups of spontaneously hypertensive rats (SHR) and Wistar (W) rats treated with atenolol during pregnancy, and lactation was evaluated. Atenolol's anti-hypertensive effect on the SHR rats was noticed from the beginning of trea
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 30(2)
A possible natriuretic mechanism of action of oxytocin was investigated in male Sprague-Dawley rats. The effects of an intravenous bolus injection of amiloride on urine volume, potassium and sodium excretion, and osmolality were measured with and wit